You are here

Study Evaluating Liver Transplantation in Haemophilia Patients in Spain

Last updated on November 13, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hemophilia, Hemophilia B
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients with haemophilia who underwent liver transplantation and who have been
followed-up at any site in Spain.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients without informed consent form.

NCT00927992
Pfizer
Completed
Study Evaluating Liver Transplantation in Haemophilia Patients in Spain

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Descriptive Information
Brief TitleStudy Evaluating Liver Transplantation in Haemophilia Patients in Spain
Official TitleLiver Transplantation in Haemophilia Patients in Spain
Brief SummaryThis study will analyze survival and outcome of patients with severe haemophilia who undergo liver transplantation in Spain
Detailed DescriptionProbability Sample
Study TypeObservational
Study DesignObservational Model: Cohort
Time Perspective: Cross-Sectional
Target Follow-Up DurationNot Provided
BiospecimenNot Provided
Sampling MethodProbability Sample
Study PopulationPatients with haemophilia who underwent liver transplantation and who have been followed-up at any site in Spain.
Condition
  • Hemophilia
  • Hemophilia B
InterventionOther: Epidemiological Non interventional
Epidemiological Non interventional
Study Groups/CohortsPatients with haemophilia who undergo liver transplantation
Patients with haemophilia who underwent liver transplantation and who have been followed up at any site in Spain.
Intervention: Other: Epidemiological Non interventional
Publications *Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment StatusCompleted
Actual Enrollment
 (submitted: December 22, 2010)
11
Original Estimated Enrollment
 (submitted: June 24, 2009)
10
Actual Study Completion DateJune 2010
Actual Primary Completion DateJune 2010   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Patients with haemophilia who underwent liver transplantation and who have been followed-up at any site in Spain.

Exclusion Criteria:

  • Patients without informed consent form.
Sex/Gender
Sexes Eligible for Study:All
AgesChild, Adult, Older Adult
Accepts Healthy VolunteersNo
ContactsContact information is only displayed when the study is recruiting subjects
Listed Location CountriesNot Provided
Removed Location CountriesSpain
 
Administrative Information
NCT NumberNCT00927992
Other Study ID NumbersB1831011
3082B1-4436 ( Other Identifier: Wyeth )
Has Data Monitoring CommitteeNo
U.S. FDA-regulated ProductNot Provided
IPD Sharing StatementNot Provided
Responsible PartyWyeth is now a wholly owned subsidiary of Pfizer
Study SponsorWyeth is now a wholly owned subsidiary of Pfizer
CollaboratorsNot Provided
Investigators
Study Director:Pfizer CT.gov Call CenterPfizer
PRS AccountWyeth is now a wholly owned subsidiary of Pfizer
Verification DateDecember 2012

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now